Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

430 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.
Nauck M, Stöckmann F, Ebert R, Creutzfeldt W. Nauck M, et al. Diabetologia. 1986 Jan;29(1):46-52. doi: 10.1007/BF02427280. Diabetologia. 1986. PMID: 3514343
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Nauck MA, et al. J Clin Endocrinol Metab. 1993 Apr;76(4):912-7. doi: 10.1210/jcem.76.4.8473405. J Clin Endocrinol Metab. 1993. PMID: 8473405 Clinical Trial.
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. Nauck MA, et al. J Clin Invest. 1993 Jan;91(1):301-7. doi: 10.1172/JCI116186. J Clin Invest. 1993. PMID: 8423228 Free PMC article. Clinical Trial.
Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man.
Reimers J, Nauck M, Creutzfeldt W, Strietzel J, Ebert R, Cantor P, Hoffmann G. Reimers J, et al. Diabetologia. 1988 May;31(5):271-80. doi: 10.1007/BF00277407. Diabetologia. 1988. PMID: 3294066
Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
Baum F, Nauck MA, Ebert R, Cantor P, Hoffmann G, Choudhury AR, Schmidt WE, Creutzfeldt W. Baum F, et al. Digestion. 1992;53(3-4):189-99. doi: 10.1159/000200994. Digestion. 1992. PMID: 1291406
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?
Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R, Siegel E, Creutzfeldt W. Niederau C, et al. Diabetologia. 1984 Jun;26(6):441-4. doi: 10.1007/BF00262217. Diabetologia. 1984. PMID: 6381191
430 results
Jump to page